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Abstract
Background: Mycoplasma hominis, a well known cause of neonatal infection, has been reported as a pathogen
in urogenital infections in adults; however, central nervous system (CNS) infections are rare. We report here the
first case of M. hominis meningitis in China, post neurosurgical treatment for an intracerebral haemorrhage in a
71-year-old male.
Case presentation: We describe a 71-year-old man who developed M. hominis meningitis after neurosurgical
treatment and was successfully treated with combined azithromycin and minocycline therapy of 2 weeks
duration, despite delayed treatment because the Gram stain of cerebrospinal fluid (CSF) yielded no visible
organisms. The diagnosis required 16S rDNA sequencing analysis of the cultured isolate from CSF. Literature
review of M. hominis CNS infections yielded 19 cases (13 instances of brain abscess, 3 of meningitis, 1 spinal
cord abscess and 1 subdural empyema each). Delay in diagnosis and initial treatment failure was evident in all
cases. With appropriate microbiological testing, antibiotic therapy (ranging from 5 days to 12 weeks) and often,
multiple surgical interventions, almost all the patients improved immediately.
Conclusions: Both our patient findings and the literature review, highlighted the pathogenic potential of
M. hominis together with the challenges prompted by rare infectious diseases in particular for developing
countries laboratories with limited diagnostic resources.
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Background
Mycoplasma hominis, initially described as pleuropne
umonia-like organism, is a commensal of the human
oral cavity, respiratory tract, and genitourinary tract
[1–3]. However, its role in the pathogenesis of infec-
tions in adult patients, especially extragenital infections
such as central nervous system (CNS) infection, post-
operative wound infections, mediastinitis, and septic
arthritis [2, 4–7], has been difficult to determine. M. homi-
nis, which does not possess a cell wall and hence is not
identifiable by Gram staining of clinical specimens, is
difficult to detect [3, 8, 9]. Culturing M. hominis which is
fastidious in nature, is both resource- and time-
consuming because specialized media and incubation
conditions are required. Direct 16S rDNA PCR amplifica-
tion/sequencing on clinical specimens may be performed
but sensitivity is moderate at best, and not all laboratories
perform this test [2, 3, 8]. The true incidence of M.
hominis infections is thus probably underestimated and
delayed diagnosis leads to delayed treatment with subopti-
mal outcomes [10].
CNS infections due to M. hominis are rare in patients
other than neonates. To the best of our knowledge, only
19 cases of such infections have been reported in the
English literature (Table 1). We herein report a case of
M. hominis meningitis in which the organism was
detected in the cerebrospinal fluid (CSF) following
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Table 1 Literature reports of CNS infections caused by Mycoplasma hominis in non-neonatal patients (1950-2016.7)
No. Author & year Pt age(years), sex Pt Country HU Tr SI Clinical manifestation Days to Dx
after Ad





1 Paine et al. [14] 20, M USA N Y Y fever, headache, a stiff neck 18 C S + P + St Sm CR [14]
2 Payan et al. [15] 29, M USA Y Y Y fever, loss of consciousness 23 C O + Cp + N + C T + E CR [15]
3 Madoff S et al. [16] 11, F USA N N Y fever 26 GIT + IRT V + E Mc De [16]
4 McMahon et al. [24] 76, M USA N N Y fever, unresponsive 18 C P + G none De [24]
5 Kersten RC et al. [17] 20, M USA Y Y Y fever, comatose 19 C A +M + Su + V + Cf M + Cf + Az + Am + Cl Re [17]
NM 35 C Az + Am + Cl M + Cf + D + Cd CR [17]
6 Cohen & Kubak. [25] 18, F USA N Y Y fever, altered mental status 20 C E D + Ci + C CR [25]
7 Zheng et al. [18] 22, F USA N N Y fever, left-sided weakness
and numbness
18 IRT + IBA Ct + N + Ca +M none CR [19]
8 Douglas et al. [19] 17, F Australia N Y Y fever, headache, photophobia,
nausea, vomiting
13 C + 16S A + Ca + E D + Cd CR [19]




C + 16S V + Cf + M Ci + M CR [20]
10 Kupila L et al. [21] 40, M Finland N Y Y haematuria and urine retention,
confused
14 16S none T CR [21]
11 McCarthy & Looke. [3] 48, M Australia N N Y fever 36 C + 16S Cz + V Ga + Cd CR [3]
12 McCarthy & Looke. [3] 17, F Australia N Y Y fever 17 C V + Me Ga +Mo CR [3]
13 Al Masalma et al. [22] 41, F Russia N N Y vertigo, coma headache,
hemiparesis
10 16S V + Me D CR [22]
14 Lee et al. [8] 48, F Netherlands Y Y Y fever 15 16S F + V Mo CR [8]
15 Henao-Martínez et al.
[10]
40, M Somalia N Y Y fever 17 C + 16S V + PT + Ct + M D CR [10]
16 Pailhorie ‘s et al. [23] 43, M France N Y Y fever, delirium tremens 13 Vitek MS + 16S Me + V + Fo L + D CR [23]
17 Whitson WJ [2] 17, M USA Y Y Y fever, bicep and deltoid
weakness
32 C PT + V + Ct + M D +Mo CR [2]
18 Hos NJ [27] 21, F Germany N N Y fever, neck pain, nausea,
vomiting,
31 C + 16S A + Ct Mo CR [27]
19 Reissier S [26] 39, M France N Y Y afbrile, loss of consciousness 33 C + 16S + RT-PCR PT + Li + Ct + Me + V Mo De [26]
20 Present study 79, M China N N Y fever, anepia and right-sided
weakness
17 16S Me + V + CF Az + D +Mi CR
Ad admitted, C culture, CR clinical recovery, De death, Dx diagnosis, GIT growth inhibition test, HU hormone use, IBA immunoblot assay, IRT immunofluo-rescence test, Otc outcome, Re recurrence, Ref reference, SI
surgical intervention, 16S 16S rDNA sequencing, RT-PCR real-time PCR, Tr trauma, yrs: years
Ampicillin, (A) amoxicillin, (Am) azithromycin, (Az) chloramphenicol, (C) cefazolin, (Ca) clindamycin, (Cd) cefotaxime, (Cf) ciprofloxacin, (Ci) clavulanate potassium, (Cl) cephalothin (Cp), ceftriaxone (Ct), ceftazidime (Cz),
cefoperazone/ sulbactam (CF), doxycycline (D), erythromycin (E),flucloxacillin (F), fosfomycin (Fo),gentamicin (G), gatifloxacin (Ga),levofloxacin (L), linezolid (Li), metronidazole (M), methacycline (Mc), meropenem (Me),













neurosurgical intervention for cerebral haemorrhage.
This is the first reported case of meningitis in an adult
caused by M. hominis from China.
Case presentation
History and first admission
The patient was a 71-year-old man with a history of
hypertension for 2 years who suddenly developed ap-
hasia, and right-sided weakness and numbness while
lifting water and was sent to the local hospital imme-
diately on 21 September 2014. A cerebral computed
tomography (CT) scan identified a cerebral hemorrhage
rupturing into the ventricular system. He underwent
craniotomy and evacuation of the hematoma. One week
after the surgery, the patient developed hospital-acquired
pneumonia, which was complicated by respiratory fail-
ure despite treatment with broad-spectrum antibiotics
of imipenem.
MICU admission
The patient was soon transferred to the medical intensive
care unit (MICU) of Peking Union Medical College
Hospital (PUMCH) on October 14. On admission, he was
febrile, comatose (Glasgow Coma Score of 9), dyspneic,
and hypotensive. Mechanical ventilation was started after
endotracheal intubation.
Examination on MICU & anti-infectious therapy
Empiric antibiotic treatment consisting of meropenem
(2.0 g intravenously q8h) and vancomycin (1.0 g in-
travenously q12h) was initiated for hospital-acquired
pneumonia. A lumbar puncture showed an opening
pressure > 33 cmH2O, 1201 x 10
6/L red cells, 201 x 106/L
white cells (79 % polymorphonuclear forms), an undetect-
able glucose concentration, protein 2.32 g/L, and chlor-
ide 128 mmol/L. No organisms were seen on Gram
stain of the CSF. A cerebral CT showed an extensive
left temporal hematoma and moderate lateral ventricle
enlargement (Fig. 1a).
During his stay in ICU, repeated cultures of tracheal
aspirates grew multidrug resistant (MDR) Acinetobacter
baumannii, which was only susceptible to cefoperazone/
sulbactam, and intermediately susceptible to tigecycline and
minocycline. A follow-up chest CT scan revealed a thick-
walled cavity in the right lower lobe (Fig. 1b). As a result,
meropenem was changed to cefoperazone/sulbactam (3.0 g
q8h), while the dose of vancomycin was increased to 1.5 g
q12h to optimize the serum trough level (Fig. 2).
Fig. 1 Computed tomography (CT) scans of the patient’s brain and lung during hospitalization. a. Cerebral CT scan revealed an extensive left
hematoma in the temporal region of the hemispheres and moderate lateral ventricle enlargement with a drainage tube in it. The hematoma was
surrounded by brain edema, narrowed gyri and the right–shifted cranial midline. b. Thoracic CT scan (lung windows) revealed a cavity with a wall of
7-mm thick surrounded by patchy shadowing in the right lower lobe. c. After 30 days of therapy, resolving brain swelling was seen in the CT scan with
decreased edema. d. After 30 days of therapy, thoracic CT scan (lung window) revealed that the area of cavitation had decreased substantially
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Etiological examination
Microbiology laboratory examination
CSF specimens were plated onto 5 % sheep blood
agar and chocolate agar and were incubated at 37 °C
under aerobic and anaerobic conditions, and in air
with 5 % CO2. On October 30, cultures revealed
non-hemolytic, semi-translucent pinpoint colonies on
sheep blood agar plate after 4 days of incubation
under anaerobic conditions (Fig. 3). Gram-stain
smears of the CSF sample showed no evidence of
bacteria.
MALDI-TOF analysis of the cultured isolate
Two systems of the matrix-assisted laser desorption/
ionization–time of flight mass spectrometry (MALDI-
TOF MS) were used, i.e. the MALDI Biotyper (Bruker)
and VITEK MS IVD (bioMérieux) as instructed by the
manufacturer. The spectra were analyzed by using the
MALDI Biotyper database library V.3.3.1.2 and the
VITEK® MS IVD v2.0 database respectively. Both
MALDI Biotyper and VITEK MS IVD consistently
yielded no identifying profile and assigned “no identifica-
tion” to this isolate.
16S rDNA gene identification
Bacterial DNA was obtained from isolates by using
QIAamp DNA minikit (Qiagen, Hilden, Germany) fol-
lowing the manufacturer’s instructions starting from
200 μL of bacterial pellet suspension about 2-3
McFarland followed by a series of extracting steps
with different reagents. Amplification of the 16S
rDNA gene was performed by broad-range bacterial
polymerase chain reaction (PCR) assay using the uni-
versal primers: 27 F (5’-AGAGTTTGATCCTGGCTC
AG-3’) and 1522R (5’-AAGGAGGTGATCCAGCCG
CA-3’) as described before [11, 12]. Purified PCR
products and sequencing primers (the same as for
amplification) were mixed and sent to Ruibiotech
(Beijing, China) for sequencing. Species identification
was performed by comparing the obtained sequences
against those in the GenBank database using the
BLASTn software (http://www.ncbi.nlm.nih.gov/blast).
By querying 16S rDNA sequences against those in the
GenBank database, the isolate best matched with 3
M. hominis reference strains (GenBank accession
numbers: CP011538.1, NR_041881.1 and CP009652.1)
with an identity of 100 % (1385/1385), followed by
Mycoplasma equirhinis, with an identity of 97 %
(1314/1353). All M. hominis 16S rDNA nucleotide
sequences available in GenBank till 2015 (n = 10) are




















































































































Meropenem Vancomycin Sulperazone Azithromycin Minocycline Temperature
Fig. 2 The correlation between the change of body temperature and the use of antibiotics during hospitalization
Fig. 3 Non-hemolytic, semi-translucent pinpoint colonies of M.
hominis were shown on 5 % blood sheep agar after 4 days
of incubation
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Post-treatment course
On November 2, the microbiology laboratory reported
isolation from the CSF sample of M. hominis, which was
susceptible to doxycycline, and intermediately suscepible
to azithromycin by the bioMérieux® SA Mycoplasma
IST2 kit (Biomerieux, France). Combination therapy
with azithromycin (0.5 g qd) and minocycline (100 mg
q12h) was then started (Fig. 2). On November 16, 14 days
after appropriate antimicrobial therapy was started, the
patient was transferred back to the local hospital. Repeated
brain and chest CT scans before discharge showed marked
improvement of the cerebral edema and size of the brain
swelling (Fig. 1c), and almost complete resolution of the
pulmonary cavity and pleural effusion (Fig. 1d).
Discussion
A PubMed search was performed using the following key
words: “Mycoplasma hominis” AND “encephalitis” OR
“cerebritis” OR “cephalitis” OR “neuraxitis” OR “phrenitis”
OR “meningitis” OR “brain abscess” OR “cranial infection”
OR "myelitis" OR " polyradiculoneuritis " OR "spinal cord
infection". A total of 58 manuscripts were found, most
reporting M. hominis infection in neonates, which most
likely arising from contact with maternal genital flora [13].
By carefully reading all the papers, we found that there
were only 19 reported non-neonatal-associated cases of
CNS infection caused by M. hominis; none was reported
from China (Table 1). Of these 20 cases, brain abscess was
the most common CNS infections (n = 13) [3, 10, 14–23],
followed by meningitis (n = 4) [8, 24–26], spinal cord ab-
scess (n = 1) [2], subdural empyema (n = 1) [27], (Table 1).
Current microbiological analysis, mostly based on direct
examination and culture of pus specimens, underestimate
the role of fastidious microorganisms, such as M. hominis
[22], in CNS infections. Predisposing host factors such as
immunosuppression, malignancy, trauma, and manipula-
tion or surgery of the genitourinary tract are considered to
be risk factors for extra-genital infections caused by this
microorganism [8, 15, 17, 18, 28]. In most M. hominis brain
infections thus far described, patients usually presented
with prior head trauma or had undergone neurosurgical
procedures [8, 10, 14, 15, 17, 19, 21, 23–27]. This was also
the case in our patient who had an intracererbal haema-
toma evacuated 7 days prior to developing meningitis.
Three routes of intracranial infection are typically
considered: direct contamination during trauma, direct
contamination during surgery, or seeding of the cerebral
site secondary to bacteraemia due to genitourinary ma-
nipulation [21, 23]. In traumatized brain tissue where
CNS capillaries are damaged, M. hominis can easily
reach the ischemic brain tissue through blood cir-
culation. In our case, the patient was exposed to the
aforementioned last 2 hypothetical sources. Cerebral
hemorrhage was cured by a neurosurgical intervention,
but he also underwent urinary catheterization after the
coma during hospitalization. Therefore, we were unable
to definitively identify the source of infection.
Identification of M. hominis infections by culture is
challenging due to the slow growth of the colonies and
the absence of cell wall, which contributes to a negative
result on Gram staining [10], as in our patient. More-
over, even when culture is successful, it is difficult to
rule out the possibility of contamination. Although M.
hominis, being less fastidious than other mycoplasmas,
is able to grow on conventional blood agar medium,
specific laboratory methods are required for its identifi-
cation. In most reports of cerebral infections, 16S rDNA
sequencing is required for definitive identification as was
the case here [8]. It has been recently highlighted that
MALDI-TOF MS could be useful for the rapid identifi-
cation of M. hominis [23, 29]. However, we were unable
to identify M. hominis by MALDI TOF MS even though
the spectra of this species is represented in the VITEK®
MS IVD v2.0 database. In this regard, similar results
were also found for the MALDI Biotyper by Nulens E
and his colleges [30]. Thus, further improvement of M.
hominis spectra database seems necessary. Nevertheless,
neither the Bruker nor Vitek database misidentified the
strain as another species.
Since cases of intracranial infections caused by M.
hominis are rare, clinicians usually fail to consider the
diagnosis in the absence of microbiological evidence. In
addition, it is difficult to distinguish brain abscesses or
meningitis caused by mycoplasmas from those caused by
bacteria or viruses, due to the lack of specific clinical
manifestations. This may lead to delayed initiation of
antimicrobial therapy with serious clinical consequence
[31], as M. hominis is not susceptible to most first-line
antibiotics used to treat brain abscesses [21]. The possi-
bility of a M. hominis infection should be suspected
when Gram stain reveals abundant neutrophils but no
bacteria, and empirical treatment shows poor efficacy
during this period.
In all previously published case studies of M. hominis
brain abscesses, treatment involved abscess drainage,
debridement, and specific antimicrobial therapy. The
importance of surgical treatment is evident from a case
report of a patient who responded to surgical therapy
alone [32]. Infections caused by Mycoplasma spp. (i.e. a
microorganism lacking both cell wall and folic acid
synthesis) require ad-hoc antibiotic treatment [33, 34].
There are no CLSI (Clinical and Laboratory Standards
Institute) and EUCAST (European Committee on An-
timicrobial Susceptibility Testing) breakpoints for M.
hominis at present. Nevertheless, the organism is gener-
ally considered to be susceptible to tetracyclines, lincosa-
mides, streptogramins and quinolones, but not to the
macrolides although tetracyclines-resistant M. hominis
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has been reported [10, 35–37]. However, poor passage
through the blood brain barrier could lead to low anti-
biotic concentrations in the brain, with the possible
major exception of fourth generation quinolones that,
besides exhibiting low MICs for M. hominis, do possess
reasonable CSF penetration [35–43]. Because of the ten-
dency for chronic and often latent infection, long-term
antimicrobial treatment against M. hominis is warranted.
However, surgical drainage and debridement remain the
key to recovery, since patients may respond to surgical
treatment alone [29].
In our case, initial treatment with meropenem and vanco-
mycin showed little efficiency since a low-grade fever still
persisted (as shown in Fig. 2). MDR A. baumannii was also
isolated from the lower respiratory tract possibly due to
nosocomial infection. Persistent fever despite various
antibiotic treatment with meropenem, vancomycin, and
cefoperazone/sulbactam, as well as the satisfactory response
to azithromycin and minocycline, strongly suggested that
M. hominis, rather than A. baumannii was the primary
pathogen in our patient.
Conclusions
The prevalence of brain infections caused by M. hominis
may be increasing, presenting a diagnostic and thera-
peutic challenge to clinicians. We reported here the first
case of meningitis caused by M. hominis in an adult in
China, who was successfully treated with azithromycin
and minocycline. The pathogenic potential of M. homi-
nis, the need for early diagnosis, and the importance of
initial appropriate chemotherapy must be highlighted
also in developing countries, where the challenges in
diagnostic capacity for clinical laboratories are greater.
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